Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kensuke Toyama

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Internal Medicine (Tokyo, Japan)|March 8, 2005
Sensorineural hearing loss combined with Takayasu's arteritisHidetomo Maruyoshi, Kensuke Toyama, Sunao Kojima, et al.
International Journal of Cardiology|October 9, 2012
Analysis of oxidative stress expressed by urinary level of 8-hydroxy-2'-deoxyguanosine and biopyrrin in atrial fibrillation: effect of sinus rhythm restorationKensuke Toyama, Hiroshige Yamabe, Takashi Uemura, et al.
Journal of General Internal Medicine|May 23, 2024
Triglyceride-Glucose Index Associated with Future Renal Function Decline in the General PopulationDaisuke Yoshida, Shota Ikeda, Keisuke Shinohara, et al.
The Laryngoscope|August 25, 2020
Low-Normal Platelets and Decreasing Platelets Are Risk Factors for Hearing Impairment DevelopmentYasunori Abe, Kensuke Toyama, Masaya Kazurayama, et al.
Anatomical Science International|December 6, 2022
Message to researchers: the characteristic absence of a posterior communicating artery is easily lost in the gerbilYasunori Abe, Kensuke Toyama, Akio Shinohara, et al.
Biochemical and Biophysical Research Communications|June 18, 2011
Telmisartan protects against diabetic vascular complications in a mouse model of obesity and type 2 diabetes, partially through peroxisome proliferator activated receptor-γ-dependent activityKensuke Toyama, Taishi Nakamura, Keiichiro Kataoka, et al.
Atherosclerosis|April 5, 2011
Rosuvastatin combined with regular exercise preserves coenzyme Q10 levels associated with a significant increase in high-density lipoprotein cholesterol in patients with coronary artery diseaseKensuke Toyama, Seigo Sugiyama, Hideki Oka, et al.
Cardiovascular Diabetology|October 27, 2014
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic miceBowen Lin, Nobutaka Koibuchi, Yu Hasegawa, et al.
American Journal of Hypertension|May 30, 2014
Telmisartan exerts sustained blood pressure control and reduces blood pressure variability in metabolic syndrome by inhibiting sympathetic activityDaisuke Sueta, Nobutaka Koibuchi, Yu Hasegawa, et al.
Journal of Cardiology|April 16, 2011
Improvement effect on endothelial function in patients with congestive heart failure treated with cardiac resynchronization therapyKoji Enomoto, Hiroshige Yamabe, Kensuke Toyama, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Internal Medicine (Tokyo, Japan)|March 8, 2005
Sensorineural hearing loss combined with Takayasu's arteritisHidetomo Maruyoshi, Kensuke Toyama, Sunao Kojima, et al.
International Journal of Cardiology|October 9, 2012
Analysis of oxidative stress expressed by urinary level of 8-hydroxy-2'-deoxyguanosine and biopyrrin in atrial fibrillation: effect of sinus rhythm restorationKensuke Toyama, Hiroshige Yamabe, Takashi Uemura, et al.
Journal of General Internal Medicine|May 23, 2024
Triglyceride-Glucose Index Associated with Future Renal Function Decline in the General PopulationDaisuke Yoshida, Shota Ikeda, Keisuke Shinohara, et al.
The Laryngoscope|August 25, 2020
Low-Normal Platelets and Decreasing Platelets Are Risk Factors for Hearing Impairment DevelopmentYasunori Abe, Kensuke Toyama, Masaya Kazurayama, et al.
Anatomical Science International|December 6, 2022
Message to researchers: the characteristic absence of a posterior communicating artery is easily lost in the gerbilYasunori Abe, Kensuke Toyama, Akio Shinohara, et al.
Biochemical and Biophysical Research Communications|June 18, 2011
Telmisartan protects against diabetic vascular complications in a mouse model of obesity and type 2 diabetes, partially through peroxisome proliferator activated receptor-γ-dependent activityKensuke Toyama, Taishi Nakamura, Keiichiro Kataoka, et al.
Atherosclerosis|April 5, 2011
Rosuvastatin combined with regular exercise preserves coenzyme Q10 levels associated with a significant increase in high-density lipoprotein cholesterol in patients with coronary artery diseaseKensuke Toyama, Seigo Sugiyama, Hideki Oka, et al.
Cardiovascular Diabetology|October 27, 2014
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic miceBowen Lin, Nobutaka Koibuchi, Yu Hasegawa, et al.
American Journal of Hypertension|May 30, 2014
Telmisartan exerts sustained blood pressure control and reduces blood pressure variability in metabolic syndrome by inhibiting sympathetic activityDaisuke Sueta, Nobutaka Koibuchi, Yu Hasegawa, et al.
Journal of Cardiology|April 16, 2011
Improvement effect on endothelial function in patients with congestive heart failure treated with cardiac resynchronization therapyKoji Enomoto, Hiroshige Yamabe, Kensuke Toyama, et al.
Pageof 7